PFE
Pfizer Inc.$26.52-0.28 (-1.03%)Prev Close$26.79·MCap$156.54B·P/E19.76·Vol36.50M·Yield0.06%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
1
$340.7K
◆
Net Activity
Net Seller
$340.7K
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at Pfizer Inc. (PFE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 1 insider sale totaling $340.7K. The most recent insider transaction was by BOSHOFF CHRISTOFFEL (President, R&D), who sold $340.7K worth of shares on Feb 2, 2026. Pfizer Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $156.54B.
PFE Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 12,887 | $26.44 | $340.7K | 0 |
| Mar 6, 2025 | DAMICO JENNIFER B. | SVP & Controller | Sell | 3,249 | $25.97 | $84.4K | 0 |
| Mar 3, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 8,909 | $26.10 | $232.5K | 0 |
| Mar 3, 2025 | BOURLA ALBERT | Chairman & CEO | Sell | 564,155 | $26.06 | $14.70M | 0 |
| Mar 3, 2025 | DAMICO JENNIFER B. | SVP & Controller | Sell | 21,547 | $26.06 | $561.5K | 0 |
| Mar 3, 2025 | Fonseca Lidia | Executive Vice President | Sell | 69,705 | $26.06 | $1.82M | 0 |
| Mar 3, 2025 | LANKLER DOUGLAS M | Executive Vice President | Sell | 150,550 | $26.06 | $3.92M | 0 |
| Mar 3, 2025 | McDermott Michael | Executive Vice President | Sell | 46,455 | $26.06 | $1.21M | 0 |
| Mar 3, 2025 | SAHNI PAYAL | Executive Vice President | Sell | 18,314 | $26.06 | $477.3K | 0 |
| Mar 3, 2025 | SUSMAN SALLY | Executive Vice President | Sell | 81,957 | $26.06 | $2.14M | 0 |
| Feb 28, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 4,872 | $26.42 | $128.7K | 0 |
| Feb 28, 2025 | McDermott Michael | Executive Vice President | Sell | 3,220 | $26.42 | $85.1K | 0 |
| Feb 25, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 1,002 | $26.30 | $26.4K | 0 |
| Feb 25, 2025 | BOURLA ALBERT | Chairman & CEO | Sell | 221,515 | $26.09 | $5.78M | 0 |
| Feb 25, 2025 | DAMICO JENNIFER B. | SVP & Controller | Sell | 8,578 | $26.10 | $223.9K | 0 |
| Feb 25, 2025 | LANKLER DOUGLAS M | Executive Vice President | Sell | 79,899 | $26.09 | $2.08M | 0 |
| Feb 25, 2025 | McDermott Michael | Executive Vice President | Sell | 10,422 | $26.09 | $271.9K | 0 |
| Feb 25, 2025 | SAHNI PAYAL | Executive Vice President | Sell | 11,911 | $26.09 | $310.8K | 0 |
| Feb 25, 2025 | SUSMAN SALLY | Executive Vice President | Sell | 59,500 | $26.09 | $1.55M | 0 |
| Feb 14, 2025 | BLAYLOCK RONALD E | Director | Buy | 19,457 | $25.65 | $499.1K | 0 |
| Feb 4, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 12,038 | $26.52 | $319.2K | 0 |
| Oct 31, 2024 | Gottlieb Scott | Director | Buy | 1,000 | $28.24 | $28.2K | 10,000 |
| Aug 14, 2024 | DAMICO JENNIFER B. | SVP & Controller | Sell | 5,154 | $28.66 | $147.7K | 8,582-38% |
| Dec 19, 2023 | Gottlieb Scott | Director | Buy | 3,000 | $26.47 | $79.4K | 9,000+50% |
| May 9, 2023 | Gottlieb Scott | Director | Buy | 2,000 | $38.50 | $77.0K | 6,000+50% |
| Mar 21, 2023 | PFIZER INC | 10% Owner | Buy | 1,811,594 | $2.76 | $5.00M | 5,952,263+44% |
| Mar 17, 2023 | DAMICO JENNIFER B. | SVP & Controller | Sell | 9,912 | $40.02 | $396.7K | 9,003-52% |
| Jun 8, 2022 | DAMICO JENNIFER B. | SVP & Controller | Sell | 4,218 | $53.96 | $227.6K | 10,846-28% |
| May 17, 2022 | DAMICO JENNIFER B. | SVP & Controller | Sell | 4,000 | $50.50 | $202.0K | 15,064 |
| May 16, 2022 | SAHNI PAYAL | Executive Vice President | Sell | 1,408 | $49.84 | $70.2K | 17,372 |
| May 13, 2022 | Carapezzi William R JR | Executive Vice President | Sell | 32,908 | $50.00 | $1.65M | 38,146-46% |
| May 13, 2022 | LANKLER DOUGLAS M | Executive Vice President | Sell | 38,273 | $49.41 | $1.89M | 78,803-33% |
| May 12, 2022 | Dolsten Mikael | President R&D | Sell | 63,902 | $49.32 | $3.15M | 397,044 |
| Dec 6, 2021 | JOHNSON RADY A | Executive Vice President | Sell | 19,000 | $53.42 | $1.02M | 74,644 |
| Dec 6, 2021 | MACKENZIE ALEXANDER R | Executive Vice President | Sell | 41,360 | $54.26 | $2.24M | 87,280-32% |
| Nov 30, 2021 | LANKLER DOUGLAS M | Executive Vice President | Sell | 40,000 | $54.37 | $2.17M | 106,193-27% |
| Nov 30, 2021 | SUSMAN SALLY | Executive Vice President | Sell | 44,308 | $54.52 | $2.42M | 133,825 |
| Nov 15, 2021 | Dolsten Mikael | President R&D | Sell | 59,664 | $50.29 | $3.00M | 337,382 |
| Nov 15, 2021 | Hwang Angela | Group President | Sell | 26,170 | $49.60 | $1.30M | 25,371-51% |
| Nov 12, 2021 | YOUNG JOHN D | Group President | Sell | 150,000 | $50.06 | $7.51M | 459,904 |
| Aug 16, 2021 | DAMICO JENNIFER B. | SVP & Controller | Sell | 1,661 | $48.30 | $80.2K | 11,429 |
| Aug 2, 2021 | DAMICO JENNIFER B. | SVP & Controller | Sell | 2,500 | $42.86 | $107.2K | 11,430 |
| May 7, 2021 | DAMICO JENNIFER B. | SVP & Controller | Sell | 2,500 | $40.82 | $102.0K | 13,748 |
PFE Insider Buying Activity
The following table shows recent insider purchases of Pfizer Inc. (PFE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | BLAYLOCK RONALD E | Director | Buy | 19,457 | $25.65 | $499.1K | 0 |
| Oct 31, 2024 | Gottlieb Scott | Director | Buy | 1,000 | $28.24 | $28.2K | 10,000 |
| Dec 19, 2023 | Gottlieb Scott | Director | Buy | 3,000 | $26.47 | $79.4K | 9,000+50% |
| May 9, 2023 | Gottlieb Scott | Director | Buy | 2,000 | $38.50 | $77.0K | 6,000+50% |
| Mar 21, 2023 | PFIZER INC | 10% Owner | Buy | 1,811,594 | $2.76 | $5.00M | 5,952,263+44% |
PFE Insider Selling Activity
The following table shows recent insider sales of Pfizer Inc. (PFE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 12,887 | $26.44 | $340.7K | 0 |
| Mar 6, 2025 | DAMICO JENNIFER B. | SVP & Controller | Sell | 3,249 | $25.97 | $84.4K | 0 |
| Mar 3, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 8,909 | $26.10 | $232.5K | 0 |
| Mar 3, 2025 | BOURLA ALBERT | Chairman & CEO | Sell | 564,155 | $26.06 | $14.70M | 0 |
| Mar 3, 2025 | DAMICO JENNIFER B. | SVP & Controller | Sell | 21,547 | $26.06 | $561.5K | 0 |
| Mar 3, 2025 | Fonseca Lidia | Executive Vice President | Sell | 69,705 | $26.06 | $1.82M | 0 |
| Mar 3, 2025 | LANKLER DOUGLAS M | Executive Vice President | Sell | 150,550 | $26.06 | $3.92M | 0 |
| Mar 3, 2025 | McDermott Michael | Executive Vice President | Sell | 46,455 | $26.06 | $1.21M | 0 |
| Mar 3, 2025 | SAHNI PAYAL | Executive Vice President | Sell | 18,314 | $26.06 | $477.3K | 0 |
| Mar 3, 2025 | SUSMAN SALLY | Executive Vice President | Sell | 81,957 | $26.06 | $2.14M | 0 |
| Feb 28, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 4,872 | $26.42 | $128.7K | 0 |
| Feb 28, 2025 | McDermott Michael | Executive Vice President | Sell | 3,220 | $26.42 | $85.1K | 0 |
| Feb 25, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 1,002 | $26.30 | $26.4K | 0 |
| Feb 25, 2025 | BOURLA ALBERT | Chairman & CEO | Sell | 221,515 | $26.09 | $5.78M | 0 |
| Feb 25, 2025 | DAMICO JENNIFER B. | SVP & Controller | Sell | 8,578 | $26.10 | $223.9K | 0 |
| Feb 25, 2025 | LANKLER DOUGLAS M | Executive Vice President | Sell | 79,899 | $26.09 | $2.08M | 0 |
| Feb 25, 2025 | McDermott Michael | Executive Vice President | Sell | 10,422 | $26.09 | $271.9K | 0 |
| Feb 25, 2025 | SAHNI PAYAL | Executive Vice President | Sell | 11,911 | $26.09 | $310.8K | 0 |
| Feb 25, 2025 | SUSMAN SALLY | Executive Vice President | Sell | 59,500 | $26.09 | $1.55M | 0 |
| Feb 4, 2025 | BOSHOFF CHRISTOFFEL | President, R&D | Sell | 12,038 | $26.52 | $319.2K | 0 |
| Aug 14, 2024 | DAMICO JENNIFER B. | SVP & Controller | Sell | 5,154 | $28.66 | $147.7K | 8,582-38% |
| Mar 17, 2023 | DAMICO JENNIFER B. | SVP & Controller | Sell | 9,912 | $40.02 | $396.7K | 9,003-52% |
| Jun 8, 2022 | DAMICO JENNIFER B. | SVP & Controller | Sell | 4,218 | $53.96 | $227.6K | 10,846-28% |
| May 17, 2022 | DAMICO JENNIFER B. | SVP & Controller | Sell | 4,000 | $50.50 | $202.0K | 15,064 |
| May 16, 2022 | SAHNI PAYAL | Executive Vice President | Sell | 1,408 | $49.84 | $70.2K | 17,372 |
| May 13, 2022 | Carapezzi William R JR | Executive Vice President | Sell | 32,908 | $50.00 | $1.65M | 38,146-46% |
| May 13, 2022 | LANKLER DOUGLAS M | Executive Vice President | Sell | 38,273 | $49.41 | $1.89M | 78,803-33% |
| May 12, 2022 | Dolsten Mikael | President R&D | Sell | 63,902 | $49.32 | $3.15M | 397,044 |
| Dec 6, 2021 | JOHNSON RADY A | Executive Vice President | Sell | 19,000 | $53.42 | $1.02M | 74,644 |
| Dec 6, 2021 | MACKENZIE ALEXANDER R | Executive Vice President | Sell | 41,360 | $54.26 | $2.24M | 87,280-32% |
| Nov 30, 2021 | LANKLER DOUGLAS M | Executive Vice President | Sell | 40,000 | $54.37 | $2.17M | 106,193-27% |
| Nov 30, 2021 | SUSMAN SALLY | Executive Vice President | Sell | 44,308 | $54.52 | $2.42M | 133,825 |
| Nov 15, 2021 | Dolsten Mikael | President R&D | Sell | 59,664 | $50.29 | $3.00M | 337,382 |
| Nov 15, 2021 | Hwang Angela | Group President | Sell | 26,170 | $49.60 | $1.30M | 25,371-51% |
| Nov 12, 2021 | YOUNG JOHN D | Group President | Sell | 150,000 | $50.06 | $7.51M | 459,904 |
| Aug 16, 2021 | DAMICO JENNIFER B. | SVP & Controller | Sell | 1,661 | $48.30 | $80.2K | 11,429 |
| Aug 2, 2021 | DAMICO JENNIFER B. | SVP & Controller | Sell | 2,500 | $42.86 | $107.2K | 11,430 |
| May 7, 2021 | DAMICO JENNIFER B. | SVP & Controller | Sell | 2,500 | $40.82 | $102.0K | 13,748 |
PFE Insiders
Similar Stocks to PFE
LLY
Eli Lilly and Company
$865.58-0.35%
$869.14B
JNJ
Johnson & Johnson
$226.84+0.65%
$555.94B
ABBV
AbbVie Inc.
$197.07-0.13%
$360.31B
MRK
Merck & Co., Inc.
$110.37+0.13%
$289.58B
AMGN
Amgen Inc.
$338.27-0.58%
$188.76B
GILD
Gilead Sciences, Inc.
$128.99+0.99%
$168.65B
BMY
Bristol-Myers Squibb Company
$58.09+0.53%
$120.73B
BIIB
Biogen Inc.
$183.22+1.33%
$26.91B